Neuro-Oncology

Top Story

Unprovoked VTE may increase risk for subsequent cancer diagnosis

February 9, 2016

Unprovoked venous thromboembolism appeared associated with a consistently high risk for subsequent cancer diagnosis, according to results of a population-based cohort study.

The risk for cancer appeared greatest in the first 6 months after VTE.

In the Journals

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs

February 8, 2016
Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping” — to prevent…

Children’s Research Institute at Children’s Mercy appoints chief scientific officer

February 6, 2016
Tom Curran, PhD, FRS, has been hired as chief scientific officer and executive director of Children’s Research Institute at Children’s Mercy Kansas City.The…
In the Journals

Adult survivors of pediatric brain tumors face significant long-term cognitive impairment

February 5, 2016
Survivors of pediatric brain tumors appeared at risk for severe cognitive impairment in adulthood, according to findings from a study conducted by researchers from St…
CME

The Patient with Severe Leukocytosis

No commercial support for this activity.

Currently five tyrosine kinase inhibitors are available for use in patients with chronic myeloid leukemia (CML)…
More »
Video

VIDEO: Effort to systematize approach to medicine has ‘taken on a life of its own’

January 20, 2016
More »
Featured
CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
In the Journals

Unprovoked VTE may increase risk for subsequent cancer diagnosis

February 9, 2016
Unprovoked venous thromboembolism appeared associated with a consistently high risk for subsequent cancer diagnosis, according to results of a…
In the Journals

Experts reveal ‘troubling’ industry-employed strategies to delay availability of generic cancer drugs

February 8, 2016
Pharmaceutical companies have employed several strategies — including reverse payment, patent settlements and “product hopping”…

Children’s Research Institute at Children’s Mercy appoints chief scientific officer

February 6, 2016
Tom Curran, PhD, FRS, has been hired as chief scientific officer and executive director of Children’s Research Institute at Children’s…
In the Journals

Adult survivors of pediatric brain tumors face significant long-term cognitive impairment

February 5, 2016
Survivors of pediatric brain tumors appeared at risk for severe cognitive impairment in adulthood, according to findings from a study conducted by…
In the JournalsPerspective

ASCO: Immunotherapy is ‘Cancer Advance of the Year’

February 4, 2016
ASCO has named progress in immunotherapy for melanoma and other malignancies as the top cancer advance of the year, according to “Clinical…
In the Journals

World Cancer Day: ‘We can’ reduce global cancer burden

February 4, 2016
Today marks the annual observation of World Cancer Day, founded by the Union for International Cancer Control to raise awareness of cancer and…

Children’s Hospital Los Angeles names director of Center for Personalized Medicine

February 3, 2016
Jaclyn Biegel, PhD, has been named director of the Center for Personalized Medicine at Children’s Hospital Los Angeles.Biegel ― known for her…
In the Journals

Proton beam therapy reduces toxicity in treatment of pediatric medulloblastoma

February 3, 2016
Proton radiotherapy appeared as effective as but less toxic than conventional photon radiotherapy for the treatment of children with medulloblastoma…

Memorial Sloan Kettering program focuses on cancer disparities among U.S. immigrants

February 1, 2016
Immigrants are considerably underserved in terms of health care in the United States. Memorial Sloan Kettering Cancer Center launched its Immigrant…
In the JournalsPerspective

Panel issues framework for allocation of scarce pediatric oncology drugs

January 29, 2016
Pediatric oncology and bioethics experts have issued a framework for the allocation of scarce drugs to reduce waste and prioritize treatment across…
More Headlines »
morganatic-roan morganatic-roan